April 11, 2013 –
Twelve years after bioengineering and chemical engineering professor Jay Keasling learned how to engineer yeast to produce the potent anti-malarial drug artemisinin, manufacturing plants are launching large-scale production of the medication.
The engineering of artemisinin is the first big success for the new field of synthetic biology, which could make this expensive treatment available to thousands of malaria sufferers around the world.
See the inspiring story and video at the Berkeley News Center.